(Q38351038)

2 September 2017

1 reference

title

Biochemistry of Parkinson's disease 28 years later: a critical review (English)

1 reference

2 September 2017

1 reference

1

Agid Y

1 reference

2 September 2017

3

Hirsch E

1 reference

2 September 2017

Cervera P

2

1 reference

2 September 2017

Javoy-Agid F

4

1 reference

2 September 2017

Lehericy S

5

1 reference

2 September 2017

Raisman R

6

1 reference

2 September 2017

Ruberg M

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

2 September 2017

1 reference

2 September 2017

volume

4 Suppl 1

1 reference

2 September 2017

page(s)

S126-44

1 reference

Aging and Extrapyramidal Function

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Biochemistry of the hypothalamus in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Is the mesocortical dopaminergic system involved in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

A comparison of clinical and pathological features of young- and old-onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040514

21 January 2018

Identifiers

DOI

10.1002/MDS.870040514

1 reference

2 September 2017

1 reference